Zepbound® coming soon — FDA-approved weight loss medication, sent to a local pharmacy you choose. Join the waitlist

Back to Peptide Guides
Guide5 min read

Navigating Insurance Coverage for GLP-1 Medications

How to maximize coverage and minimize costs for Zepbound, Wegovy, and other GLP-1 prescriptions

Why Insurance Coverage Is Complicated

GLP-1 medications sit at a frustrating intersection of insurance policy. Here's why coverage is inconsistent:

  • Weight loss vs. diabetes indication: Many insurers cover GLP-1 medications for type 2 diabetes but explicitly exclude them for weight management
  • Prior authorization: Most plans require your provider to submit documentation proving medical necessity before they'll approve the prescription
  • Step therapy: Some plans require you to try (and fail) cheaper medications first
  • Formulary tiers: Even when covered, GLP-1 medications are often placed on the highest cost-sharing tier

The result is that two patients with the same medical profile can face wildly different out-of-pocket costs depending on their employer's plan design.

Step 1: Check Your Formulary

A formulary is your insurance plan's list of covered medications, organized by cost tiers. Here's how to check yours:

  1. Log into your insurance portal or call the member services number on your card
  2. Search for the specific medication name (Zepbound, Wegovy, Mounjaro, Ozempic)
  3. Note which tier it falls on (Tier 1 is cheapest, Tier 4-5 is most expensive)
  4. Check for any coverage exclusions for weight management indications
  5. Look for quantity limits or prior authorization requirements

Tip: If your plan excludes weight management drugs but covers diabetes drugs, and you have type 2 diabetes, your provider may be able to prescribe Mounjaro or Ozempic under the diabetes indication.

Step 2: Understand Prior Authorization

Prior authorization (PA) is your insurer's way of verifying that a medication is medically necessary before they agree to pay. For GLP-1 medications, a strong PA submission typically includes:

  • Current BMI (must meet FDA-approved thresholds)
  • Weight-related comorbidities (type 2 diabetes, hypertension, dyslipidemia, sleep apnea)
  • Documentation of failed lifestyle interventions (diet programs, exercise regimens, prior medication trials)
  • Lab work (A1c, lipid panel, metabolic panel)

PA processing usually takes 3-10 business days. If approved, it's typically valid for 6-12 months before requiring renewal.

Step 3: Know Your Options by Scenario

If Your Insurance Covers Zepbound

DetailInfo
Savings ProgramZepbound Savings Card
Your CostAs low as $25 per fill
EligibilityCommercial insurance (not government)
Fills CoveredUp to 13 fills
Expiration12/31/2026

If Your Insurance Covers Wegovy

Novo Nordisk offers savings programs for commercially insured patients. Check NovoCare.com for current offers and eligibility. Programs and copay amounts change periodically.

If Your Insurance Doesn't Cover GLP-1 Medications

LillyDirect (Zepbound self-pay):

  • $299-$449 per month depending on dose (Journey Program pricing)
  • Ships directly from Lilly's fulfillment pharmacy
  • 45-day refill window
  • No insurance needed — this is a cash-pay option

NovoCare (Wegovy/Ozempic self-pay):

  • Novo Nordisk's patient support program
  • Pricing and availability vary — check NovoCare.com for current offers

If You Have Medicare, Medicaid, or Tricare

Manufacturer savings cards are NOT eligible for government insurance programs. This is a federal regulation, not a manufacturer decision.

However, the TREAT Act (Treat and Reduce Obesity Act) is legislation that, if passed, would require Medicare to cover FDA-approved anti-obesity medications. This could significantly expand access for Medicare beneficiaries.

Step 4: Appeal Denials

If your prior authorization is denied, you have the right to appeal. Here's how:

  1. Request the denial reason in writing — your insurer must explain why they denied the claim
  2. Ask your provider to submit a peer-to-peer review — a direct conversation between your doctor and the insurer's medical reviewer often resolves denials
  3. File a formal appeal with additional supporting documentation
  4. External review — if the internal appeal is denied, most states allow an independent external review

Common Denial Reasons and How to Address Them

Denial ReasonHow to Address
BMI doesn't meet criteriaEnsure BMI is calculated correctly and documented in recent visit notes
No documented lifestyle interventionProvide records of diet counseling, gym membership, prior program enrollment
Step therapy not completedDocument prior medication trials and why they were insufficient
Excluded benefit (weight management)Check if diabetes or cardiovascular indication applies
Not on formularyRequest a formulary exception with medical necessity letter

What Valitide Does

Navigating insurance for GLP-1 medications shouldn't be a second job. Here's what Valitide handles for you:

  • Insurance verification: We check your specific plan's formulary and coverage before prescribing
  • Prior authorization: Our team prepares and submits PA documentation with the clinical detail insurers need to approve
  • Savings program enrollment: We enroll eligible patients in manufacturer savings cards (Zepbound Savings Card, Novo Nordisk programs)
  • Alternative pathways: When insurance doesn't cover, we route you to manufacturer-direct pricing like LillyDirect's Journey Program
  • Denial support: If a PA is denied, we handle the appeal process

Important Reminders

  • Government insurance (Medicare, Medicaid, Tricare, VA) cannot use manufacturer savings cards — this is a federal law
  • Savings programs have expiration dates and fill limits — always verify current terms
  • Coverage policies change frequently — what was denied six months ago may be approved today
  • Keep copies of all documentation, denial letters, and appeal submissions

Prescription peptide access is coming

Join the waitlist to be notified when legal peptide access through licensed providers launches.

Learn more about what's coming →